Human immunodeficiency virus type-1 and chemokines: Beyond competition for common cellular receptors

Cytokine and Growth Factor Reviews

Volumn 12, Issue 2-3, 2001, Pages 219-243

  Stantchev, Tzanko S ^a   Broder, Christopher C ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Chemokine; Chemokine receptor; Gp120; Human immunodeficiency virus; Receptor; Signaling; Tat

Indexed keywords

CD4 ANTIGEN; CELL RECEPTOR; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; HETEROTRIMERIC GTP BINDING PROTEINS; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; OLIGOMER; TRANSACTIVATOR PROTEIN; VIRUS RECEPTOR;

BINDING COMPETITION; CELL MEMBRANE; CONFORMATIONAL TRANSITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MEMBRANE FUSION; NONHUMAN; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; VIRUS ENVELOPE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

ANTIGENS, CD4; BINDING, COMPETITIVE; CHEMOKINES; GENE PRODUCTS, TAT; HETEROTRIMERIC GTP-BINDING PROTEINS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; RECEPTORS, CHEMOKINE; RECEPTORS, HIV; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; RNA VIRUSES;

EID: 0034955071     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(00)00033-2     Document Type: Review

References (272)

1. Host factors and the pathogenesis of HIV-induced disease
2. Virus receptors: Binding, adhesion strengthening, and changes in viral structure
3. Introduction
4. Cellular receptors and viral glycoproteins involved in retrovirus entry
5. Retrovirus receptors
6. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
7. Coreceptor use by primate lentiviruses
8. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
9. Beyond receptor expression: The influence of receptor conformation, density, and affinity in HIV-1 infection
10. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: Induction and enhancement by soluble CD4
11. CD4-independent infection by HIV-2 Is mediated by fusin/CXCR4
12. Chemokine and orphan receptors in HIV-2 and SIV tropism and pathogenesis
13. G protein-coupled receptors. I. Diversity of receptor-ligand interactions
14. Molecular tinkering of G protein-coupled receptors: An evolutionary success
15. Expanding horizons for receptors coupled to G proteins: Diversity and disease
16. The many faces of G protein signaling
17. Crystal structure of rhodopsin: A G protein-coupled receptor
18. Activation of phospholipase C by cholecystokinin receptor subtypes with different G-protein-coupling specificities in hormone-secreting pancreatic cell lines
19. G-protein regulatory pathways: Rocketing into the twenty-first century
20. G protein beta gamma subunits
21. Type-specific regulation of mammalian adenylyl cyclases by G protein pathways
22. Signaling by distinct classes of phosphoinositide 3-kinases
23. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades
24. Chemokine-induced monocyte transmigration requires cdc42-mediated cytoskeletal changes
25. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5
26. Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk
27. Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK
28. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: Roles of phosphoinositide-3 kinase and protein kinase C
29. Stromal cell-derived factor-1alpha and stem cell factor/kit ligand share signaling pathways in hemopoietic progenitors: A potential mechanism for cooperative induction of chemotaxis
30. Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: Implications for chemotaxis
31. Signaling through focal adhesion kinase
32. Regulation of phosphoinositide-specific phospholipase C isozymes
33. Regulation of tyrosine kinase cascades by G-protein-coupled receptors
34. The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor
35. Mitogenic signaling via G protein-coupled receptors
36. Regulation of cell proliferation by G proteins
37. Regulation of cell cycle re-entry by growth, survival and stress signalling pathways
38. GTPase-activating proteins for heterotrimeric g proteins: Regulators of G protein signaling (RGS) and RGS-like proteins
39. Functional roles of the two domains of phosducin and phosducin-like protein
40. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization
41. Desensitization of G-protein-coupled receptors in the cardiovascular system
42. Beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis
43. Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors
44. Opiates transdeactivate chemokine receptors: Delta and mu opiate receptor-mediated heterologous desensitization
45. Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes
46. International union of pharmacology. XXII. Nomenclature for chemokine receptors
47. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo
48. Human CC chemokine I-309, structural consequences of the additional disulfide bond
49. NMR studies of active N-terminal peptides of stromal cell-derived factor-1. Structural basis for receptor binding
50. Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation
51. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1
52. Human chemokines: An update
53. Chemokines: Understanding their role in T-lymphocyte biology
54. Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction
55. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct
56. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation
57. The second extracellular loop of CCR5 is the major determinant of ligand specificity
58. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein
59. Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function
60. Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity
61. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions
62. Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides
63. Five-transmembrane domains appear sufficient for a G protein-coupled receptor: Functional five-transmembrane domain chemokine receptors
64. Inhibition of G-protein-coupled receptor function by disruption of transmembrane domain interactions
65. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2
66. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway
67. Chemokine receptors: Structure, function and role in microbial pathogenesis
68. Chemokines activate natural killer cells through heterotrimeric G-proteins: Implications for the treatment of AIDS and cancer
69. Differential regulation of G-protein-mediated signaling by chemokine receptors
70. Selective G protein coupling by C-C chemokine receptors
71. Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes
72. Interferon-inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins
73. Leukocyte polarization in cell migration and immune interactions
74. Macrophage inflammatory protein-1 alpha enhances growth factor-stimulated phosphatidylcholine metabolism and increases cAMP levels in the human growth factor-dependent cell line M07e, events associated with growth suppression
75. Mammalian adenylyl cyclases
76. Tailoring cAMP-signalling responses through isoform multiplicity
77. The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor
78. RANTES and MIP-1alpha activate stats in T cells
79. RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells
80. Novel association of the src family kinases, hck and c-fgr, with CCR3 receptor stimulation: A possible mechanism for eotaxin-induced human eosinophil chemotaxis
81. Activation of dual T cell signaling pathways by the chemokine RANTES
82. Tyrosine phosphorylation of a low molecular weight protein induced by RANTES in T-lymphocytes
83. RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation
84. Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutants
85. Enhancement of human immunodeficiency virus type 1 infection by the CC- chemokine RANTES is independent of the mechanism of virus-cell fusion
86. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity
87. RANTES-induced T cell activation correlates with CD3 expression
88. Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans
89. Definition, function and pathophysiological significance of chemokine receptors
90. Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling
91. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine
92. Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases
93. The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways
94. The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes
95. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
96. Abnormal chemokine-induced responses of immature and mature hematopoietic cells from motheaten mice implicate the protein tyrosine phosphatase SHP-1 in chemokine responses
97. Positive and negative regulation of leukocyte activation by protein tyrosine phosphatases
98. B cell antigen receptor engagement inhibits stromal cell-derived factor (SDF)-1alpha chemotaxis and promotes protein kinase C (PKC)-induced internalization of CXCR4
99. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement
100. Active movement of T cells away from a chemokine
101. HIV-1 attachment another look
102. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
103. Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages
104. Are beta-chemokines innocent bystanders in HIV type 1 disease progression?
105. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines
106. Beta-chemokines and protection from HIV type 1 disease
107. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs
108. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
109. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
110. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor
111. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
112. New targets for inhibitors of HIV-1 replication
113. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization
114. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans
115. Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans
116. Identification of RANTES, MIP-1 alpha, and MIP-1beta as the major HIV- suppressive factors produced by CD8+ T cells
117. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
118. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines
119. Role of beta-chemokines in suppressing HIV replication
120. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells
121. Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors
122. Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors
123. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC- CKR-5
124. Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia
125. CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1beta, suppress HIV-1 replication in monocyte/macrophages
126. Chemokines and HIV replication
127. The inhibitory effect of RANTES on the infection of primary macrophages by R5 human immunodeficiency virus type-1 depends on the macrophage activation state
128. Effect of beta-chemokines on human immunodeficiency virus type 1 replication, binding, uncoating, and CCR5 receptor expression in human monocyte-derived macrophages
129. The immunopathogenesis of HIV infection
130. Consistent and significant inhibition of human immunodeficiency virus type 1 envelope-mediated membrane fusion by beta-chemokines (RANTES) in primary human macrophages
131. Effect of RANTES on the infection of monocyte-derived primary macrophages by human immunodeficiency virus type 1 and type 2
132. Enhancement of HIV-1 replication in human macrophages is induced by CD8+ T cell soluble factors
133. Chemokine immunobiology in HIV-1 pathogenesis
134. Chemokine production in HIV-seropositive long-term asymptomatic individuals
135. Do beta-chemokines have clinical relevance in HIV infection?
136. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection
137. CD8+ cells in HIV infection produce macrophage inflammatory protein-1 alpha and RANTES: A comparative study in long-term survivors and progressor patients
138. Differences in HIV replication in CD4+ lymphocytes are not related to beta-chemokine production
139. Production of beta-chemokines in human immunodeficiency virus (HIV) infection: Evidence that high levels of macrophage inflammatory protein- 1beta are associated with a decreased risk of HIV disease progression
140. Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status
141. Sustained suppression of plasma HIV RNA is associated with an increase in the production of mitogen-induced MIP-1alpha and MIP-1beta
142. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages
143. Acquisition of HIV type 1 resistance by beta-chemokine-producing CD4+ T cells
144. Human immunodeficiency virus type 1 infection of antigen-specific CD4 cytotoxic T lymphocytes
145. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro
146. Mechanisms of resistance to HIV infection
147. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: Association with low expression of CCR5 and high production of beta-chemokines
148. C-C chemokines, pivotal in protection against HIV type 1 infection
149. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR- 5 allele
150. Circulating levels of RANTES in human immunodeficiency virus type 1 infection: Effect of potent antiretroviral therapy
151. Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection
152. Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients
153. Increased intracellular macrophage inflammatory protein-1beta correlates with advanced HIV disease
154. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines
155. Chemokines and chemokine receptors in T-cell priming and Th1/Th2- mediated responses
156. Enhanced HIV-1 replication by chemokines constitutively expressed in secondary lymphoid tissues
157. Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication
158. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: Role of signal transduction
159. HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands
160. Human leucocyte heparan sulphate proteoglycans and their roles in inflammation
161. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines
162. CREB and COUPTF mediate transcriptional activation of the human immunodeficiency virus type 1 genome in Jurkat T cells in response to cyclic AMP and dopamine
163. Prostaglandin E2 Up-regulates HIV-1 long terminal repeat-driven gene activity in T cells via NF-kappaB-dependent and -independent signaling pathways
164. cAMP stimulates human immunodeficiency virus (HIV-1) from latently infected cells of monocyte-macrophage lineage: Synergism with TNF-alpha
165. The cAMP-dependent protein kinase A and protein kinase C-beta pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage
166. Human immunodeficiency virus-1 infection requires pertussis toxin sensitive G-protein-coupled signalling and mediates cAMP downregulation
167. Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: Involvement of NF-kappaB and NFAT
168. Infection of CD4+ memory T cells by HIV-1 requires expression of phosphodiesterase 4
169. Nuclear import of HIV-1 DNA in resting CD4+ T cells requires a cyclosporin A-sensitive pathway
170. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
171. Formation of simian immunodeficiency virus long terminal repeat circles in resting T cells requires both T cell receptor- and IL-2-dependent activation
172. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions
173. CD3- and CD28-dependent induction of PDE7 required for T cell activation
174. Sumatriptan increases the proliferation of peripheral blood mononuclear cells from HIV-infected individuals and healthy blood donors in vitro
175. Serotonin modulates immune function in T cells from HIV-seropositive subjects
176. Bidirectional signaling between the cytoskeleton and integrins
177. Modulation of HIV-1 replication by a novel RhoA effector activity
178. Cyclic AMP inhibitors inhibits PDGF-stimulated mitogen-activated protein kinase activity in rat aortic smooth muscle cells via inactivation of c-Raf-1 kinase and induction of MAP kinase phosphatase-1
179. Nerve growth factor-stimulated B-Raf catalytic activity is refractory to inhibition by cAMP-dependent protein kinase
180. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes
181. Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway
182. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA
183. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase
184. Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro
185. Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase
186. Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: Downregulation of CCR5 expression by cyclic adenosine monophosphate
187. cAMP up-regulates cell surface expression of lymphocyte CXCR4: Implications for chemotaxis and HIV-1 infection
188. Defective signal transduction - A common pathway for cellular dysfunction in HIV infection?
189. HIV infection and signal transduction
190. HIV1 Nef: The Machiavelli of cellular activation
191. Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes
192. HIV-1 Nef protein: An invitation to a kill
193. Mechanisms of HIV-associated lymphocyte apoptosis
194. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
195. HIV-1 Tat: A polypeptide for all seasons
196. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains
197. Selective CXCR4 antagonism by tat: Implications for in vivo expansion of coreceptor use by HIV-1
198. Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS
199. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia
200. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: Suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1
201. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression
202. HIV-1 Tat protein mimicry of chemokines
203. Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
204. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: A rationale for the use of Tat toxoid as an HIV-1 vaccine
205. Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques
206. Good or evil: CD26 and HIV infection
207. CD26, let it cut or cut it down
208. The unique properties of dipeptidyl-peptidase IV (DPP IV/CD26) and the therapeutic potential of DPP IV inhibitors
209. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: A subverted adhesion molecule for HIV peptide binding
210. The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth
211. Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals
212. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness
213. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule
214. The role of CD4 in HIV envelope-mediated pathogenesis
215. Envelope glycoproteins of human immunodeficiency virus type 1: Profound influences on immune functions
216. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation
217. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
218. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis
219. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
220. HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells
221. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation
222. Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4+ T cells
223. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes
224. Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4
225. HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5
226. Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines
227. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity
228. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: Independence from G protein signaling and importance of coreceptor downmodulation
229. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
230. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains
231. Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells
232. Interference with the signaling capacity of CC chemokine receptor 5 can compromise its role as an HIV-1 entry coreceptor in primary T lymphocytes
233. Varying effects of temperature, Ca(2+) and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins
234. Signaling through the cAMP messenger system CD4 dynamic interactions among CXCR4 in CCR5-significance env dependent fusion in monocytes/macrophages
235. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1
236. Beyond receptor expression: The influence of receptor conformation, density, and affinity in HIV-1 infection
237. A mechanism of resistance to HIV-1 entry: Inefficient interactions of CXCR4 with CD4 and gp120 in macrophages
238. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1
239. The effect of p56lck, a lymphocyte specific protein tyrosine kinase, on the syncytium formation induced by human immunodeficiency virus envelope glycoprotein
240. Inhibition of HIV-1 X4 env-mediated cell fusion by the tyrosine kinase inhibitor herbimycin A
241. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization
242. Lipid rafts and signal transduction
243. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts
244. Cell biology of virus entry
245. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5
246. The role of lipid rafts in T cell antigen receptor (TCR) signalling
247. Phorbol ester-induced disruption of the CD4-Lck complex occurs within a detergent-resistant microdomain of the plasma membrane. Involvement of the translocation of activated protein kinase C isoforms
248. Membrane raft microdomains mediate front-rear polarity in migrating cells
249. T lymphocyte costimulation mediated by reorganization of membrane microdomains
250. Differential regulation of CXCR4 and CCR5 endocytosis
251. Endocytic and exocytic regulation of CD4 expression and function
252. Amyloid precursor protein, although partially detergent-insoluble in mouse cerebral cortex, behaves as an atypical lipid raft protein
253. Direct visualization of HIV-1 entry: Mechanisms and role of cell surface receptors
254. Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
255. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy
256. Points of convergence between Ca2+ and Ras signalling pathways
257. G protein-coupled-receptor cross-talk: The fine-tuning of multiple receptor-signalling pathways
258. Pak to the future
259. Organization and regulation of mitogen-activated protein kinase signaling pathways
260. Signaling to Rho GTPases
261. Phosphatidylinositol-3 kinase dependent pathways: The role in control of cell growth, survival, and malignant transformation
262. The hallmarks of cancer
263. Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope
264. A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis
265. Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway
266. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway
267. Sequestration of p56(lck) by gp120, a model for TCR desensitization
268. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: Implications for human immunodeficiency virus type 1-associated dementia
269. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: Implications for HIV pathogenesis